Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2017-07-21 2017-07-21
Drug Identification Number 02358093 02358093
Brand name RAN-NABILONE RAN-NABILONE
Common or Proper name RAN-NABILONE RAN-NABILONE
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients NABILONE NABILONE
Strength(s) 1MG 1MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A04AD A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-07-12 2017-07-12
Actual discontinuation date 2017-07-12 2017-07-12
Remaining supply date 2017-07-12 2017-07-12
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments